Abaxis Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Abaxis Inc inventory turnover ratio, the Abaxis Inc's ability to sell and replace its inventory in the fourth quarter 2018, sequentially increased to 2.74 in the fourth quarter 2018, yet the ratio remained below the average, as ABAX's market remain challenging.Average inventory processing period, for the Abaxis Inc in Mar 31 2018 quarter, has decreased to 133 days, compare to 138 days, in the Dec 31 2017 quarter.

Within Healthcare sector 186 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the IV Quarter 2018, to 1514, from total ranking in the third quarter 2018 at 1556.

ABAX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Abaxis Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ABAX Inventory Turnover Ratio	(Mar 31 2018) IV. Quarter	(Dec 31 2017) III. Quarter	(Sep 30 2017) II. Quarter	(Jun 30 2017) II. Quarter	(Mar 31 2017) IV. Quarter
Y / Y Inventory Growth	13.1 %	8.44 %	7.77 %	13.83 %	11.04 %
Y / Y Cost of Sales Growth	28.9 %	17.66 %	1.52 %	2.41 %	5.49 %
Inventory Turnover Ratio (TTM)	2.74	2.64	2.6	2.63	2.7
ABAX's Total Ranking	# 1514	# 1556	# 1485	# 1508	#
Average inventory processing period	133	138	141	139	135
Seq. Inventory Growth	3.82 %	8.83 %	-3.74 %	4 %	-0.46 %
Seq. Cost of Sales Growth	21.98 %	3 %	1.44 %	1.14 %	11.34 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 7
Healthcare Sector	# 187
Overall Market	# 1514

Inventory Turnover Ratio Statistics
High	Average	Low
3.7	2.95	2.44
(Mar 31 2013)		(Dec 31 2015)

ABAX Company Profile >> Back to ABAX Efficiency Comparisons >> Compare ABAX Inventory Turnover Ratio to its Competitors

Financial Statements
Abaxis Inc's Inventories	$ 44 Millions	Visit ABAX's Balance sheet
Abaxis Inc's Cost of Revenues TTM	$ 114 Millions	Visit ABAX's Income Statement
What are ABAX's Sales?		Visit ABAX's Sales by Segment

Other Inventory Turnover Ratios
Abaxis Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ABAX's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ABAX's Competitors
Inventory Turnover Ratio for ABAX's Suppliers
Inventory Turnover Ratio for ABAX's Customers

You may also want to know
ABAX's Sales Growth Rates	ABAX's Pe Price to earnings ratio	ABAX's Receivables Turnover Ratio	ABAX's Stock Quote
ABAX's Net Income Growth Rates	ABAX's Ps Price to Sales ratio	ABAX's Sales per Employee	ABAX's Asset Turnover Ratio
ABAX's Net Margin	ABAX's Pb Price to Book ratio	ABAX's Financial Strength Ratios	ABAX's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2018, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2018	Inventories at quarter ending Mar 31 2018
Steris Plc	7.04	$ 1,525.773 Millions	$ 217 Millions
Veracyte Inc	7.02	$ 29.765 Millions	$ 4 Millions
Horizon Therapeutics Public Limited Company	6.92	$ 515.028 Millions	$ 74 Millions
Assertio Holdings inc	6.81	$ 66.868 Millions	$ 10 Millions
Cytosorbents Corporation	6.75	$ 5.832 Millions	$ 1 Millions
Collegium Pharmaceutical Inc	6.70	$ 45.330 Millions	$ 7 Millions
Harrow Inc	6.70	$ 14.219 Millions	$ 2 Millions
Lantheus Holdings Inc	6.56	$ 167.967 Millions	$ 26 Millions
Carlisle Companies Incorporated	6.50	$ 3,067.600 Millions	$ 472 Millions
Neurometrix Inc	6.47	$ 10.493 Millions	$ 2 Millions
Enzo Biochem Inc	6.46	$ 46.885 Millions	$ 7 Millions
Omnova Solutions Inc	6.24	$ 489.200 Millions	$ 78 Millions
Innovage Holding Corp	6.14	$ 7.067 Millions	$ 1 Millions
Insulet Corporation	5.95	$ 192.047 Millions	$ 32 Millions
Mannkind Corporation	5.82	$ 18.688 Millions	$ 3 Millions
Wellness Center Usa Inc	5.55	$ 0.068 Millions	$ 0 Millions
Avanos Medical Inc	5.48	$ 1,068.700 Millions	$ 195 Millions
Micron Solutions Inc	5.40	$ 17.828 Millions	$ 3 Millions
Tearlab Corp	5.35	$ 12.230 Millions	$ 2 Millions
Nuvectra Corp	5.33	$ 21.342 Millions	$ 4 Millions
Dexcom Inc	5.33	$ 243.700 Millions	$ 46 Millions
Patterson Companies Inc	5.27	$ 4,266.317 Millions	$ 809 Millions
Bristol myers Squibb Company	5.26	$ 6,391.000 Millions	$ 1,216 Millions
Idexx Laboratories Inc	5.23	$ 902.403 Millions	$ 172 Millions
Aptevo Therapeutics Inc	5.23	$ 15.087 Millions	$ 3 Millions
West Pharmaceutical Services Inc	5.19	$ 1,114.200 Millions	$ 215 Millions
Henry Schein Inc	5.15	$ 9,287.259 Millions	$ 1,802 Millions
Enovis Corp	5.15	$ 2,315.455 Millions	$ 450 Millions
Sensus Healthcare Inc	5.13	$ 7.303 Millions	$ 1 Millions
Dmk Pharmaceuticals Corporation	5.12	$ 7.819 Millions	$ 2 Millions

Date modified: 2026-07-06T17:55:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.